{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:27:51Z","timestamp":1787020071281,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>BKPyV associated hemorrhagic cystitis (BKPyV-HC) is a major and prevalent outcome of hematopoietic stem cell transplantation (HSCT) with no standard treatment option. Adoptive T cell therapy (ACT) against transplant-associated viruses has shown promising potential. We sought to produce virus-specific T cells (VSTs) against BKPyV with the aim of treating refractory HSCT-associated HC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral blood mononuclear cells (PBMC) from healthy donors were isolated by Ficoll-Hypaque density gradient centrifugation. BKPyV-pulsed, monocyte-derived dendritic cells (mo-DCs) and T cells were co-cultured and expanded over 2\u20133\u00a0weeks with the addition of IL-2. The T cells were examined for various functional assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comparison analysis of Carboxyfluorescein diacetate succinimidyl ester (CFSE) indicated that the percentage of proliferated cells were significantly higher in donors (49.62\u2009\u00b1\u20097.09%) than controls (7.96\u2009\u00b1\u20094.55%). Furthermore, expanded T cells exhibited specificity to BKPyV antigens by IFN-\u03b3 ELISPOT assay. The expanded cells showed cytotoxic function versus human lymphoblastoid cell line (LCL). Final VST products mainly comprised of CD8\/CD69 double-positive T cells, which were significantly higher in donors (46.8\u2009\u00b1\u20097.1%) than controls (16.91\u2009\u00b1\u20093.40%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study we demonstrated the feasibility of producing functional BKPyV-specific T cells in healthy donors using BKPyV PepMixes. These functional cells were able to proliferate and produce IFN-\u03b3 cytokine in response to BKPyV PepMixes. In addition, these T cells had cytotoxic ability against BKPyV antigen-expressing target cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12865-022-00497-1","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T09:19:30Z","timestamp":1654852770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In Vitro\u00a0Generation of BK polyomavirus-specific T cells for adoptive cell therapy in refractory cystitis hemorrhagic patients after hematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"23","author":[{"given":"Maryam Mohammadi","family":"Najafabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ahmadvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina Soufi","family":"Zomorrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seied Asadollah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"497_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010047","author":"G Ottaviano","year":"2019","unstructured":"Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, Veys P, Todryk S. Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8010047.","journal-title":"Cells"},{"key":"497_CR2","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3389\/fimmu.2017.01272","volume":"8","author":"A Houghtelin","year":"2017","unstructured":"Houghtelin A, Bollard CM. Virus-specific T cells for the immunocompromised patient. Front Immunol. 2017;8:1272.","journal-title":"Front Immunol"},{"key":"497_CR3","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813\u201326.","journal-title":"N Engl J Med"},{"key":"497_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4067\/S0716-97602012000300012","volume":"45","author":"F Barriga","year":"2012","unstructured":"Barriga F, Ram\u00edrez P, Wietstruck A, Rojas N. Hematopoietic stem cell transplantation: clinical use and perspectives. Biol Res. 2012;45:307\u201316.","journal-title":"Biol Res"},{"key":"497_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-019-0701-1","volume":"12","author":"T Kaeuferle","year":"2019","unstructured":"Kaeuferle T, Krauss R, Blaeschke F, Willier S, Feuchtinger T. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation. J Hematol Oncol. 2019;12:13.","journal-title":"J Hematol Oncol"},{"key":"497_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbmt.2013.05.014","volume":"19","author":"RQ Kloos","year":"2013","unstructured":"Kloos RQ, Boelens JJ, de Jong TP, Versluys B, Bierings M. Hemorrhagic cystitis in a cohort of pediatric transplantations: incidence, treatment, outcome, and risk factors. Biol Blood Marrow Transplant. 2013;19:1263\u20136.","journal-title":"Biol Blood Marrow Transplant"},{"key":"497_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1182\/bloodadvances.2019000802","volume":"4","author":"H Imlay","year":"2020","unstructured":"Imlay H, Xie H, Leisenring WM, Duke ER, Kimball LE, Huang ML, Pergam SA, Hill JA, Jerome KR, Milano F, Nichols WG, Pang PS, Hirsch HH, Limaye AP, Boeckh M. Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Blood Adv. 2020;4:617\u201328.","journal-title":"Blood Adv"},{"key":"497_CR8","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/bmt.2015.162","volume":"50","author":"LE Lunde","year":"2015","unstructured":"Lunde LE, Dasaraju S, Cao Q, Cohn CS, Reding M, Bejanyan N, Trottier B, Rogosheske J, Brunstein C, Warlick E, Young JA, Weisdorf DJ, Ustun C. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone marrow transplant. 2015;50:1432\u20137.","journal-title":"Bone marrow transplant"},{"key":"497_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jac\/dky158","volume":"73","author":"S Cesaro","year":"2018","unstructured":"Cesaro S, Dalianis T, Hanssen Rinaldo C, Koskenvuo M, Pegoraro A, Einsele H, Cordonnier C, Hirsch HH. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother. 2018;73:12\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"497_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12914","volume":"20","author":"L Schneidewind","year":"2018","unstructured":"Schneidewind L, Neumann T, Schmidt CA, Kruger W. Comparison of intravenous or intravesical cidofovir in the treatment of BK polyomavirus-associated hemorrhagic cystitis following adult allogeneic stem cell transplantation-a systematic review. Transpl Infect Dis. 2018;20: e12914.","journal-title":"Transpl Infect Dis"},{"key":"497_CR11","first-page":"217","volume":"10","author":"M Mohammadi Najafabadi","year":"2020","unstructured":"Mohammadi Najafabadi M, Soleimani M, Ahmadvand M, Soufi Zomorrod M, Mousavi SA. Treatment protocols for BK virus associated hemorrhagic cystitis after hematopoietic stem cell transplantation. Am J Blood Res. 2020;10:217\u201330.","journal-title":"Am J Blood Res"},{"key":"497_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/CMR.00074-16","volume":"30","author":"GR Ambalathingal","year":"2017","unstructured":"Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R. BK Polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev. 2017;30:503\u201328.","journal-title":"Clin Microbiol Rev"},{"key":"497_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1086\/599829","volume":"49","author":"S Cesaro","year":"2009","unstructured":"Cesaro S, Hirsch HH, Faraci M, Owoc-Lempach J, Beltrame A, Tendas A, Baltadakis I, Dalle JH, Koc Y, Toporski J, Styczynski J, Yesilipek MA, Heinz W, Caniglia M, Rascon J, Fauser AA, Michallet M, Lopez-Corral L, Neuburger S, Tridello G, Einsele H. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis. 2009;49:233\u201340.","journal-title":"Clin Infect Dis"},{"key":"497_CR14","first-page":"93","volume":"65","author":"R Arora","year":"2017","unstructured":"Arora R, Jasmita SM, Garg A, Gupta GM, N,. Successful treatment of BK virus hemorrhagic cystitis (HC) post allogenic hematopoietic stem cell transplantation with low dose Cidofovir. J Assoc Physicians India. 2017;65:93\u20134.","journal-title":"J Assoc Physicians India"},{"key":"497_CR15","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.bbmt.2018.04.009","volume":"24","author":"EA Coomes","year":"2018","unstructured":"Coomes EA, Wolfe Jacques A, Michelis FV, Kim DDH, Thyagu S, Viswabandya A, Lipton JH, Messner HA, Deotare U. Efficacy of cidofovir in treatment of BK virus-induced hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2018;24:1901\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"key":"497_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/bmt.2016.17","volume":"51","author":"RJ O'Reilly","year":"2016","unstructured":"O\u2019Reilly RJ, Prockop S, Hasan AN, Koehne G, Doubrovina E. Virus-specific T-cell banks for \u201coff the shelf\u201d adoptive therapy of refractory infections. Bone Marrow Transplant. 2016;51:1163\u201372.","journal-title":"Bone Marrow Transplant"},{"key":"497_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1056\/NEJMoa1801540","volume":"379","author":"M Muftuoglu","year":"2018","unstructured":"Muftuoglu M, Olson A, Marin D, Ahmed S, Mulanovich V, Tummala S, Chi TL, Ferrajoli A, Kaur I, Li L, Champlin R, Shpall EJ, Rezvani K. Allogeneic BK virus-specific T cells for progressive multifocal leukoencephalopathy. New Engl J Med. 2018;379:1443\u201351.","journal-title":"New Engl J Med"},{"key":"497_CR18","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1182\/blood.V128.22.5726.5726","volume":"128","author":"OM Pello","year":"2016","unstructured":"Pello OM, Bradshaw A, Innes A, Finn S-A, Bray E, Uddin S, Olavarria E, Apperley JF, Pavl\u016f J. Clinical efficacy of BK virus specific T-cells in treatment of severe refractory hemorrhagic cystitis after HLA haploidentical transplantation. Blood. 2016;128:5726\u20135726.","journal-title":"Blood"},{"key":"497_CR19","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/bloodadvances.2019001120","volume":"4","author":"E Espada","year":"2020","unstructured":"Espada E, Cheng MP, Kim HT, Woolley AE, Avigan JI, Forcade E, Soares MVD, Lacerda JF, Nikiforow S, Gooptu M, Romee R, Alyea EP, Armand P, Cutler CS, Ho VT, Koreth J, Antin JH, Soiffer RJ, Marty FM, Ritz J. BK virus\u2013specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation. Blood Adv. 2020;4:1881\u201393.","journal-title":"Blood Adv"},{"key":"497_CR20","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1097\/TP.0000000000001698","volume":"101","author":"C Lamarche","year":"2017","unstructured":"Lamarche C, Orio J, Georges-Tobar V, Pincez T, Goupil M, Dahmani A, Carli C, Brasey A, Busque L, Delisle JS. Clinical-scale rapid autologous BK virus-specific T cell line generation from kidney transplant recipients with active viremia for adoptive immunotherapy. Transplantation. 2017;101:2713\u201321.","journal-title":"Transplantation"},{"key":"497_CR21","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1073\/pnas.1812800116","volume":"116","author":"A Mayer","year":"2019","unstructured":"Mayer A, Zhang Y, Perelson AS, Wingreen NS. Regulation of T cell expansion by antigen presentation dynamics. Proc Natl Acad Sci. 2019;116:5914\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"497_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02987","author":"V Kalia","year":"2018","unstructured":"Kalia V, Sarkar S. Regulation of effector and memory CD8 T cell differentiation by IL-2\u2014a balancing act. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.02987.","journal-title":"Front Immunol"},{"key":"497_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtm.2017.02.001","volume":"5","author":"H Dave","year":"2017","unstructured":"Dave H, Luo M, Blaney JW, Patel S, Barese C, Cruz CR, Shpall EJ, Bollard CM, Hanley PJ. Toward a rapid production of multivirus-specific T cells targeting BKV, adenovirus, CMV, and EBV from umbilical cord blood. Mol Ther Methods Clin Dev. 2017;5:13\u201321.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"497_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/TP.0b013e31823328c0","volume":"92","author":"E Blyth","year":"2011","unstructured":"Blyth E, Clancy L, Simms R, Gaundar S, O\u2019Connell P, Micklethwaite K, Gottlieb DJ. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses. Transplantation. 2011;92:1077\u201384.","journal-title":"Transplantation"},{"key":"497_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/apm.12981","volume":"127","author":"S Ghaffari","year":"2019","unstructured":"Ghaffari S, Torabi-Rahvar M, Omidkhoda A, Ahmadbeigi N. Impact of various culture conditions on ex vivo expansion of polyclonal T cells for adoptive immunotherapy. APMIS. 2019;127:737\u201345.","journal-title":"APMIS"},{"key":"497_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12865-021-00435-7","volume":"22","author":"S Ghaffari","year":"2021","unstructured":"Ghaffari S, Torabi-Rahvar M, Aghayan S, Jabbarpour Z, Moradzadeh K, Omidkhoda A, Ahmadbeigi N. Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy. BMC Immunol. 2021;22:43.","journal-title":"BMC Immunol"},{"key":"497_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3324\/haematol.2018.206896","volume":"105","author":"S Vasileiou","year":"2020","unstructured":"Vasileiou S, Turney AM, Kuvalekar M, Mukhi SS, Watanabe A, Lulla P, Ramos CA, Naik S, Vera JF, Tzannou I, Leen AM. Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections. Haematologica. 2020;105:235\u201343.","journal-title":"Haematologica"},{"key":"497_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4137\/VRT.S942","volume":"1","author":"J Li","year":"2008","unstructured":"Li J, Mookerjee B, Wagner SP, JL,. Generation of BKV-specific T cells for adoptive therapy against BKV nephropathy. Virol Res Treat. 2008;1:942.","journal-title":"Virol Res Treat"},{"key":"497_CR29","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1097\/01.ASN.0000096374.08473.E3","volume":"14","author":"P Comoli","year":"2003","unstructured":"Comoli P, Basso S, Azzi A, Moretta A, De Santis R, Del Galdo F, De Palma R, Valente U, Nocera A, Perfumo F, Locatelli F, Maccario R, Ginevri F. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. J Am Soc Nephrol. 2003;14:3197\u2013204.","journal-title":"J Am Soc Nephrol"},{"key":"497_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibri\u00e1n","year":"2017","unstructured":"Cibri\u00e1n D, S\u00e1nchez-Madrid F. CD69: from activation marker to metabolic gatekeeper. Eur J Immunol. 2017;47:946\u201353.","journal-title":"Eur J Immunol"},{"key":"497_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/cyto.a.22317","volume":"83","author":"P Bacher","year":"2013","unstructured":"Bacher P, Scheffold A. Flow-cytometric analysis of rare antigen-specific T cells. Cytom A. 2013;83:692\u2013701.","journal-title":"Cytom A"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-022-00497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-022-00497-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-022-00497-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T09:20:31Z","timestamp":1654852831000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-022-00497-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["497"],"URL":"https:\/\/doi.org\/10.1186\/s12865-022-00497-1","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"26 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This experimental study has been reviewed and approved by ethics committee of Tarbiat Modares University (IR.MODARES.REC.1398.220). All experiments were performed in accordance with relevant guidelines and regulations. All donors signed a written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}